Need help with injection technique
Retatrutide is still in the trial phase, but it is showing greater weight loss potential than the others and may become the preferred option once it is granted approval
A gentle 10 to 15 minute walk after eating helps stimulate gastric motility without the jarring movements that worsen reflux
Viking Therapeutics enters the back half of 2026 holding $502 million in cash and two fully enrolled Phase 3 trials, which means the next meaningful test of its obesity franchise is no longer about enrollment mechanics but about whether the efficacy signal seen in earlier work holds at scale
Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor
This means Retatrutide can support people to reduce weight in three ways: Suppress appetite and slow digestion, meaning youre not as hungry as often and feel fuller for longer Increase fat metabolism, so your body breaks down fat quicker Increase insulin sensitivity, which reduces blood sugar, causing the body to break down stored fat What does Retatrutide treat